145 related articles for article (PubMed ID: 25715421)
1. Remission of severe neonatal diabetes with very early sulfonylurea treatment.
Marshall BA; Green RP; Wambach J; White NH; Remedi MS; Nichols CG
Diabetes Care; 2015 Mar; 38(3):e38-9. PubMed ID: 25715421
[No Abstract] [Full Text] [Related]
2. [Neonatal diabetes mellitus: treatment with sulfonylurea in a preterm born infant].
Wendelin G; Haim M; Reiterer F; Borkenstein M; Müller W
Klin Padiatr; 2009; 221(2):100. PubMed ID: 19263329
[No Abstract] [Full Text] [Related]
3. Sulfonylurea-responsive diabetes in childhood.
Landau Z; Wainstein J; Hanukoglu A; Tuval M; Lavie J; Glaser B
J Pediatr; 2007 May; 150(5):553-5. PubMed ID: 17452235
[TBL] [Abstract][Full Text] [Related]
4. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
Sperling MA
N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555
[No Abstract] [Full Text] [Related]
5. Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation.
Philla KQ; Bauer AJ; Vogt KS; Greeley SA
Diabetes Care; 2013 Dec; 36(12):e201. PubMed ID: 24265373
[No Abstract] [Full Text] [Related]
6. Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.
Lemelman MB; Letourneau L; Greeley SAW
Clin Perinatol; 2018 Mar; 45(1):41-59. PubMed ID: 29406006
[TBL] [Abstract][Full Text] [Related]
7. [Diabetes: new drugs?].
Codaccioni JL; Fontaine G
Sem Hop; 1976 May; 52(20):1243-5. PubMed ID: 189407
[No Abstract] [Full Text] [Related]
8. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
Ješić MM; Ješić MD; Maglajlić S; Sajić S; Necić S
Diabetes Res Clin Pract; 2011 Jan; 91(1):e1-3. PubMed ID: 21056492
[TBL] [Abstract][Full Text] [Related]
9. Treatment with glibenclamide in maturity-onset diabetes mellitus.
Persson I; Madsen SN
Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
[No Abstract] [Full Text] [Related]
10. First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment.
Ioacara S; Flanagan S; Fröhlich-Reiterer E; Goland R; Fica S
J Diabetes Investig; 2017 Sep; 8(5):716-719. PubMed ID: 28083968
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylurea treatment in young children with neonatal diabetes: dealing with hyperglycemia, hypoglycemia, and sick days.
Codner E; Flanagan SE; Ugarte F; García H; Vidal T; Ellard S; Hattersley AT
Diabetes Care; 2007 May; 30(5):e28-9. PubMed ID: 17337505
[No Abstract] [Full Text] [Related]
12. Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease: impact of low compliance to the gluten free diet.
Delvecchio M; Zecchino C; Faienza MF; Acquafredda A; Barbetti F; Cavallo L
Diabetes Res Clin Pract; 2009 Jun; 84(3):332-4. PubMed ID: 19345438
[TBL] [Abstract][Full Text] [Related]
13. [Glibenclamide: its therapeutic effect in diabetes mellitus].
Concha E; Veit O
Rev Med Chil; 1971 Mar; 99(3):217-9. PubMed ID: 4999506
[No Abstract] [Full Text] [Related]
14. To diet or not to diet in neonatal diabetes responding to sulfonylurea treatment.
Ioacara S; Sava E; Barosan A; Cojocaru F; Gutan A; Fica S
J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1053-1056. PubMed ID: 30016278
[TBL] [Abstract][Full Text] [Related]
15. Oral management of uncomplicated maturity onset diabetes.
Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
[No Abstract] [Full Text] [Related]
16. Symposium on diabetes mellitus and oral hypoglycaemic drugs. Summary.
Taft P
Aust N Z J Med; 1971 Aug; 1():Suppl 2:83-5. PubMed ID: 5005135
[No Abstract] [Full Text] [Related]
17. Acute sulfonylurea therapy at disease onset can cause permanent remission of KATP-induced diabetes.
Remedi MS; Agapova SE; Vyas AK; Hruz PW; Nichols CG
Diabetes; 2011 Oct; 60(10):2515-22. PubMed ID: 21813803
[TBL] [Abstract][Full Text] [Related]
18. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
19. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
[No Abstract] [Full Text] [Related]
20. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
Vernet A; Fabre J; Zahnd G
Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
[No Abstract] [Full Text] [Related]
[Next] [New Search]
